Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Liquid biopsy

Diagnostics Genetics and epigenetics

Uncovering Brain Tumor Biomarkers in Blood and CSF

| Olivia Gaskill

Tapping into CSF and blood may overcome the challenges of diagnosing and monitoring brain tumors

Subspecialties Liquid biopsy

Secrets in Circulating Tumor Biomarkers

| Michael Schubert

What ctDNA and CTCs can tell us about the likelihood of breast cancer survival and recurrence

Diagnostics Digital and computational pathology

Capturing Cancer Through CTCs

| Michael Schubert

A new algorithm may help identify rare circulating tumor cells to improve liquid biopsy

Inside the Lab Liquid biopsy

Liquid Biopsy Insights into Cancer

| Sponsored by Illumina

Liquid biopsy is minimally invasive and easily accessible – but what information can a new multiplexed assay provide from circulating tumor DNA?

Subspecialties Clinical care

Seeking Out Sepsis

| Michael Schubert

A new, biomarker-based test may allow sepsis diagnosis and intervention before patients become symptomatic

Diagnostics Clinical care

A Step Forward for CRC Screening

| Michael Schubert

To improve cancer screening compliance, patients may benefit from sensitive, specific, noninvasive blood tests

Diagnostics Liquid biopsy

Combining Urine Biomarkers for Prostate Cancer

| Luke Turner

A new combination of urine biomarkers could help avoid the 60 percent of unnecessary biopsies for prostate cancer

Subspecialties Liquid biopsy

A Chip for Liquid Biopsy

| Michael Schubert

A new microfluidic chip analyzes urine samples to detect prostate cancer cells.

Diagnostics Liquid biopsy

Test, Treat, Repeat

| Alexandra Pender, Natacha Entz-Werle

New ctDNA biomarkers could lead to more informed treatment decisions for patients with advanced non-small cell lung cancer and pediatric osteosarcoma

Subspecialties Neurology

Predicting Prognosis in Glioblastoma

| Luke Turner

A link between cfDNA concentration and progression-free survival in glioblastoma patients supports the use of liquid biopsy when predicting prognosis


Sister Publications

You might be interested in our Sister Publications:

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register